150 related articles for article (PubMed ID: 30236507)
21. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Uesaka K; Boku N; Fukutomi A; Okamura Y; Konishi M; Matsumoto I; Kaneoka Y; Shimizu Y; Nakamori S; Sakamoto H; Morinaga S; Kainuma O; Imai K; Sata N; Hishinuma S; Ojima H; Yamaguchi R; Hirano S; Sudo T; Ohashi Y;
Lancet; 2016 Jul; 388(10041):248-57. PubMed ID: 27265347
[TBL] [Abstract][Full Text] [Related]
22. Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan: A Systematic Review and Network Meta-analysis.
Takumoto Y; Sasahara Y; Narimatsu H; Akazawa M
JAMA Netw Open; 2022 Jan; 5(1):e2145515. PubMed ID: 35099549
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of systemic chemotherapy for unresectable gallbladder carcinoma].
Shimizu J; Dono K; Fujino S; Hata T; Kitahara T; Yanagawa T; Munakata K; Watanabe N; Takamoto K; Nagai K; Miyake M; Hata T; Kawanishi K; Ikeda K; Fujita J; Akagi K; Iwazawa T; Kitada M; Shimano T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2708-10. PubMed ID: 21224687
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer.
Sudo K; Yamaguchi T; Nakamura K; Denda T; Hara T; Ishihara T; Yokosuka O
Cancer Chemother Pharmacol; 2011 Feb; 67(2):249-54. PubMed ID: 20352216
[TBL] [Abstract][Full Text] [Related]
25. Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent.
Seki Y; Okusaka T; Ikeda M; Morizane C; Ueno H
Jpn J Clin Oncol; 2009 Nov; 39(11):751-5. PubMed ID: 19666905
[TBL] [Abstract][Full Text] [Related]
26. S-1 vs. gemcitabine as an adjuvant therapy after surgical resection for ductal adenocarcinoma of the pancreas.
Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Kozuki A; Tokumaru T; Iiyama T; Kosaki T; Kobayashi M; Hanazaki K
World J Surg; 2014 Nov; 38(11):2986-93. PubMed ID: 25104544
[TBL] [Abstract][Full Text] [Related]
27. Modified FOLFIRINOX for Locally Advanced and Metastatic Pancreatic Cancer Patients Resistant to Gemcitabine and S-1 in Japan: A Single Institutional Experience.
Umemura A; Nitta H; Sasaki A; Takahara T; Hasegawa Y; Wakabayashi G
Hepatogastroenterology; 2014 May; 61(131):814-20. PubMed ID: 26176079
[TBL] [Abstract][Full Text] [Related]
28. [A three-week regimen of S-1 monotherapy reduced gastrointestinal toxicity and maintained efficacy in patients with gemcitabine-refractory advanced pancreatic cancer].
Tanaka H; Mitsunaga S; Kobayashi M; Funazaki H; Katayama S; Kuwahara A; Okuyama H; Takahashi H; Ohno I; Shimizu S; Sakamoto Y; Kondo S; Morizane C; Ueno H; Okusaka T; Ochiai A; Ikeda M
Gan To Kagaku Ryoho; 2015 Mar; 42(3):313-7. PubMed ID: 25812499
[TBL] [Abstract][Full Text] [Related]
29. Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
Park SJ; Kim H; Shin K; Hong TH; Suh JH; Lee MA
BMC Cancer; 2021 Nov; 21(1):1176. PubMed ID: 34732161
[TBL] [Abstract][Full Text] [Related]
30. [The progress of chemotherapy for advanced pancreatic cancer].
Ioka T; Katayama K; Ashida R; Takahashi H; Teshima T; Sakon M
Nihon Shokakibyo Gakkai Zasshi; 2015 Dec; 112(12):2119-26. PubMed ID: 26638783
[No Abstract] [Full Text] [Related]
31. A retrospective study of S-1 monotherapy as second-line treatment for patients with advanced biliary tract cancer.
Kobayashi S; Ueno M; Ohkawa S; Andou T; Kameda R; Yamamoto N; Morinaga S
Jpn J Clin Oncol; 2012 Sep; 42(9):800-6. PubMed ID: 22826349
[TBL] [Abstract][Full Text] [Related]
32. [A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy].
Omori K; Wakabayashi K; Suematsu Y; Suda H; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Ito Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1582-4. PubMed ID: 26805103
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysis.
Lu S; Zhang Y; Zhou X; Zhou D; Yang Q; Ju B; Zhao X; Hu Z; Xie H; Zhou L; Zheng S; Wang W
Sci Rep; 2016 Nov; 6():36944. PubMed ID: 27833144
[TBL] [Abstract][Full Text] [Related]
34. [A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer].
Miyagawa K; Yata Y; Yamaoka N; Sagara Y
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1145-7. PubMed ID: 20567125
[TBL] [Abstract][Full Text] [Related]
35. Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01).
Maeda A; Boku N; Fukutomi A; Kondo S; Kinoshita T; Nagino M; Uesaka K
Jpn J Clin Oncol; 2008 Mar; 38(3):227-9. PubMed ID: 18272475
[TBL] [Abstract][Full Text] [Related]
36. Gemcitabine plus S-1 for metastatic pancreatic cancer.
Zhu H; Yi C; Zhao Y; Gou H
Medicine (Baltimore); 2018 Oct; 97(41):e12836. PubMed ID: 30313120
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of Gemcitabine and S-1 for Patients with Advanced Pancreatic Cancer.
Cheng YJ; Meng CT; Shao YJ; Li NN; Zhou N; Yan XY; Gao X; Zhou JF; Bai CM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):562-567. PubMed ID: 28877836
[TBL] [Abstract][Full Text] [Related]
38. [A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].
Ohara T; Fujino Y; Goto H; Yamashita H; Oyama M; Katsura M; Sugiyama H; Ueda Y; Hasegawa H; Yasuda T; Kakinoki K; Oshikiri T; Sendo H; Sugimoto T; Tominaga M
Gan To Kagaku Ryoho; 2015 May; 42(5):633-5. PubMed ID: 25981662
[TBL] [Abstract][Full Text] [Related]
39. Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma.
Yamagishi Y; Higuchi H; Izumiya M; Sakai G; Iizuka H; Nakamura S; Adachi M; Hozawa S; Takaishi H; Hibi T
J Gastroenterol; 2010 Nov; 45(11):1146-54. PubMed ID: 20549255
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Kobayashi H; Kondo N; Nakagawa N; Sueda T
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):306-13. PubMed ID: 22270151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
